InsidersTradesSigma
Follow the Monopar Therapeutics Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 7 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Arthur Klausner. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration